Literature DB >> 8229481

First-phase insulin release in normal children.

H F Allen1, B W Jeffers, G J Klingensmith, H P Chase.   

Abstract

Normal values for the first-phase insulin release during an intravenous glucose tolerance test are not yet well defined for children and adolescents. In this study, 69 normal subjects (aged 7 to 22 years) who had no family history of type I diabetes, a normal glycohemoglobin value, and a negative islet cell antibody test result underwent a standard intravenous glucose tolerance test. The mean (+/- SEM) first-phase insulin release increased with age and pubertal status: 7 to 10 years, 93 +/- 10.1 mIU/L; 11 to 15 years, 172.7 +/- 22.3 mIU/L; and 16 to 22 years, 163 +/- 28.5 mIU/L. The mean intraindividual variability in 11 subjects who underwent a second test was 23.6%. Acute stress, as estimated by observer assessment or by blood catecholamine levels, did not significantly correlate with first-phase insulin release. We conclude that first-phase insulin release is markedly lower in prepubertal children than in adolescents and young adults.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8229481     DOI: 10.1016/s0022-3476(05)80847-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

1.  Normal values of first-phase insulin response to intravenous glucose in healthy Italian children and adolescents.

Authors:  R Lorini; M Vanelli
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

Review 2.  Strategies for preventing type I diabetes mellitus.

Authors:  C F Verge; G S Eisenbarth
Journal:  West J Med       Date:  1996-03

3.  Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing.

Authors:  Jennifer M Barker; Kim McFann; Leonard C Harrison; Spiros Fourlanos; Jeffrey Krischer; David Cuthbertson; H Peter Chase; George S Eisenbarth
Journal:  J Pediatr       Date:  2007-01       Impact factor: 4.406

4.  Comparison of two insulin assays for first-phase insulin release in type 1 diabetes prediction and prevention studies.

Authors:  Jeffrey L Mahon; Craig A Beam; Santica M Marcovina; David C Boulware; Jerry P Palmer; William E Winter; Jay S Skyler; Jeffrey P Krischer
Journal:  Clin Chim Acta       Date:  2011-08-06       Impact factor: 3.786

5.  First test effect in intravenous glucose tolerance testing.

Authors:  Heba M Ismail; Kama S White; Jeffrey P Krischer; H Peter Chase; David Cuthbertson; Jerry P Palmer
Journal:  Pediatr Diabetes       Date:  2013-08-15       Impact factor: 4.866

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.